These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 35505024)

  • 1. Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy.
    de Keijzer MJ; de Klerk DJ; de Haan LR; van Kooten RT; Franchi LP; Dias LM; Kleijn TG; van Doorn DJ; Heger M;
    Methods Mol Biol; 2022; 2451():285-403. PubMed ID: 35505024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.
    Broekgaarden M; Weijer R; van Gulik TM; Hamblin MR; Heger M
    Cancer Metastasis Rev; 2015 Dec; 34(4):643-90. PubMed ID: 26516076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional activation of HIF-1 by a ROS-ERK axis underlies the resistance to photodynamic therapy.
    Lamberti MJ; Pansa MF; Vera RE; Fernández-Zapico ME; Rumie Vittar NB; Rivarola VA
    PLoS One; 2017; 12(5):e0177801. PubMed ID: 28545088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy.
    Cai Z; Xin F; Wei Z; Wu M; Lin X; Du X; Chen G; Zhang D; Zhang Z; Liu X; Yao C
    Adv Healthc Mater; 2020 Jan; 9(1):e1900996. PubMed ID: 31746153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy.
    Ji Z; Yang G; Shahzidi S; Tkacz-Stachowska K; Suo Z; Nesland JM; Peng Q
    Cancer Lett; 2006 Dec; 244(2):182-9. PubMed ID: 16427735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH.
    Zhang Z; Wang R; Huang X; Luo R; Xue J; Gao J; Liu W; Liu F; Feng F; Qu W
    ACS Appl Mater Interfaces; 2020 Feb; 12(5):5680-5694. PubMed ID: 31944660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Rectifiable and Hypoxia-Assisted Chemo-Photodynamic Nanoinhibitor for Synergistic Cancer Therapy.
    Wang Y; Huo J; Li S; Huang R; Fan D; Cheng H; Wan B; Du Y; He H; Zhang G
    ACS Appl Mater Interfaces; 2022 Mar; 14(8):10092-10101. PubMed ID: 35170301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for Improving Photodynamic Therapy Through Pharmacological Modulation of the Immediate Early Stress Response.
    de Klerk DJ; de Keijzer MJ; Dias LM; Heemskerk J; de Haan LR; Kleijn TG; Franchi LP; Heger M;
    Methods Mol Biol; 2022; 2451():405-480. PubMed ID: 35505025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H
    Chen K; Zhai Y; Wang Y; Xu Z; Chen X; Zhang Y; Zhou Z; Zheng X; Lin F
    Biomed Pharmacother; 2024 Aug; 177():117110. PubMed ID: 39002439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in strategies for overcoming hypoxia in photodynamic therapy of cancer.
    Pucelik B; Sułek A; Barzowska A; Dąbrowski JM
    Cancer Lett; 2020 Nov; 492():116-135. PubMed ID: 32693200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-OMIC profiling of survival and metabolic signaling networks in cells subjected to photodynamic therapy.
    Weijer R; Clavier S; Zaal EA; Pijls MM; van Kooten RT; Vermaas K; Leen R; Jongejan A; Moerland PD; van Kampen AH; van Kuilenburg AB; Berkers CR; Lemeer S; Heger M
    Cell Mol Life Sci; 2017 Mar; 74(6):1133-1151. PubMed ID: 27803950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
    Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
    Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells.
    Weijer R; Broekgaarden M; van Golen RF; Bulle E; Nieuwenhuis E; Jongejan A; Moerland PD; van Kampen AH; van Gulik TM; Heger M
    BMC Cancer; 2015 Dec; 15():1014. PubMed ID: 26705830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conquering the Hypoxia Limitation for Photodynamic Therapy.
    Wan Y; Fu LH; Li C; Lin J; Huang P
    Adv Mater; 2021 Dec; 33(48):e2103978. PubMed ID: 34580926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel HIF-1α/VMP1-autophagic pathway induces resistance to photodynamic therapy in colon cancer cells.
    Rodríguez ME; Catrinacio C; Ropolo A; Rivarola VA; Vaccaro MI
    Photochem Photobiol Sci; 2017 Nov; 16(11):1631-1642. PubMed ID: 28936522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Low to No O
    Li M; Xu Y; Peng X; Kim JS
    Acc Chem Res; 2022 Nov; 55(22):3253-3264. PubMed ID: 36323625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.
    Guo X; Qu J; Zhu C; Li W; Luo L; Yang J; Yin X; Li Q; Du Y; Chen D; Qiu Y; Lou Y; You J
    Drug Deliv; 2018 Nov; 25(1):585-599. PubMed ID: 29461122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Bromopyruvate-Conjugated Nanoplatform-Induced Pro-Death Autophagy for Enhanced Photodynamic Therapy against Hypoxic Tumor.
    Deng Y; Song P; Chen X; Huang Y; Hong L; Jin Q; Ji J
    ACS Nano; 2020 Aug; 14(8):9711-9727. PubMed ID: 32806075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codelivery of High-Molecular-Weight Poly-porphyrins and HIF-1α Inhibitors for
    He J; Xia K; Zhao B; Song W; Zheng Y; Xiao G; Wu H; Zheng N
    Biomacromolecules; 2021 Nov; 22(11):4783-4793. PubMed ID: 34623134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bufalin exacerbates Photodynamic therapy of colorectal cancer by targeting SRC-3/HIF-1α pathway.
    Yuan Z; Liu C; Sun Y; Li Y; Wu H; Ma S; Shang J; Zhan Y; Yin P; Gao F
    Int J Pharm; 2022 Aug; 624():122018. PubMed ID: 35839982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.